Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_917_Библиотеки_им_академика_М_И_Перельмана.pdf
Скачиваний:
0
Добавлен:
31.08.2026
Размер:
32 Мб
Скачать
118
Table 9.3 Half-life and washout time of biologic treatments for IBD
Medication Iniximab 8–9.5 40–47.5
Adalimumab 14 70 Certolizumab 14 70 Golimumab 9–15 45–75 Vedolizumab 25 125 Natalizumab 10–11 40–45 Ustekinumab 15(IV)
Tofacitinib 0.13 3
Half-lives and washout times for biologic therapies for IBD listed in days (IV intravenous, SQ subcutaneous)
Half-life (d)
45.6 (SQ)
S. Eisenstein and A. L. Grucela
Washout (d)
75 (IV) 228 (SQ)
multiple biologics likely have the most severe disease. This needs to be taken into consideration when planning surgery, and these patients should be treated as though they have more severe illness than they may exhibit. A common approach to patients on biologics is to wait until they are at the nadir of their dose, usually around the time they are about to receive their next dose, delay that dose, perform their surgery, and restart medication if medically necessary several weeks after surgery. It should be remembered that these patients still have active therapy in their system, and the only true way to ensure there is no drug present is to allow for a full washout which is equivalent to ve half-lives of the medication (Table9.3).
Ideally, chemotherapy should be allowed to wash out of the patient’s system prior to undergoing elective colorectal procedures. Chemotherapy can impair wound healing, cause myelosuppression, impair immune responses, and lead to a variety of other different issues which can increase the risk of postoperative complications. When feasible, it is best to wait at least 6weeks after any dose of chemotherapy to allow for washout. This is particularly true of bevacizumab, a monoclonal antibody against vascular endothelial growth factor (VEGF), which impairs angiogenesis. These patients are at a signicant risk of postoperative bleeding. Waiting for surgery is not always feasible, and in the acute setting, patients undergoing chemotherapy sometimes require urgent surgical intervention. When this occurs, it is always important to take the chemotherapy into consideration when planning the type of surgery and consider smaller, more temporizing procedures knowing that signi­cant intervention may lead to signicant complication.
Smokers
Smoking is a well-documented risk factor for complications after colon and rectal surgery. Smoking has shown to contribute to increased risk of VTE, wound infec­tion, anastomotic dehiscence, and hernia formation [2325]. The effects of smoking on the airway are also extensive. Carbon monoxide has deleterious effects on the cardiovascular system and can persist for several hours after inhalation. Airway sensitivity is increased, and these effects last 2–10days after inhalation. Mucus secretion is also altered, and these effects can last for many weeks [26]. Smoking cessation should be instituted at least 4 weeks prior to surgery, and it has been
9 Checklist forPatients andOR Team inPreparation forLaparoscopic Colorectal…
119
shown that there is increasing benet for every week beyond 4 that the patient is able to stop smoking [23]. However, for those who have quit smoking for less than 4weeks, the alteration of mucus secretion may lead to greater risk of respiratory complications from general anesthesia, and ideally it is best to wait until mucus secretion and cilliation returns to its normal state [26].
One should consider canceling elective surgery in patients who are actively smoking, and any patient who actively smokes and presents for surgery should be counseled on smoking cessation techniques. The surgeon should seek help from the patient’s primary care physician as they will often have a greater depth of experi­ence in assisting the patients to adequate cessation. Several aides have also been used in promoting smoking cessation. These include varenicline, bupropion, and nicotine replacement. In a randomized controlled trial, varenicline demonstrated a
3.6-fold increase in smoking cessation compared to placebo, while bupropion and nicotine replacement demonstrated a two-fold increase [27].
These techniques for smoking cessation are often not effective, and so many surgeons will test their patient’s blood, urine, or saliva for nicotine or the by-product of nicotine metabolism cotinine. Nicotine will only stay positive on a blood test for several days after consumption, whereas cotinine may remain positive for several weeks and is therefore a better test of long-term cessation than nicotine testing alone. It should be noted that patients taking nicotine replacement will also test positive for nicotine and cotinine, and so this should be taken into consideration when counseling patients on their optimal cessation technique.
Malnutrition
It is also critical to ensure your patient’s nutritional status is optimized prior to undergoing major abdominal surgery. Nutrition can be measured in many different ways, whether its body mass index (BMI), weight loss, or hypoalbuminemia. It is important to take all of these into consideration when evaluating a patient for sur­gery, but the single best test is likely hypoalbuminemia, which has been shown to be the best predictor of most surgical complications as well as length of stay and over­all complication rates when compared to weight loss and BMI in patients with colorectal cancer [28]. Malnutrition has been shown to increase the risk of almost every potential complication, from a variety of infectious and septic conditions, to VTE and DVT, to anesthesia-related complications, as poor nutrition impairs every major organ system, leaving patients open to postoperative dysfunction.
Improving upon patient nutrition prior to surgical intervention is necessary to minimize the risk of complications. Patients who are at risk for malnutrition should be assessed prior to surgery with an albumin and prealbumin levels. It should be remembered that albumin is a better marker of chronic nutrition with a half-life of 20–22days, while prealbumin has a half-life of 2–4days and is a better gauge of the direction a patient’s nutrition is trending. If a patient is determined to be malnour­ished, then intervention should be considered. Intervention should be chosen based on the factors which led to the patient’s malnutrition as well as the acuity of the problem and the timing of surgical intervention. Generally those who are in a cata­bolic condition should take in between 1.5 and 1.8g of protein per Kg of body
120
S. Eisenstein and A. L. Grucela
weight per day [29]. Vitamin D supplementation can also help increase muscle mass and should also be considered [29].
Standard dietary supplementation with high-quality protein supplements (>30g protein/serving) can be helpful, particularly if there is only mild malnutrition. Total parenteral nutrition (TPN) should be considered in patients who are unable to take enteral nutrition. These patients are at higher risk of line-related complications, but this risk is trivial in comparison with those complications that the patient may encounter due to their malnutrition. Enteral nutrition (EN) consists of elemental or semi-elemental feeds delivered to the gut which recently has been shown to be the preferred approach when possible. These data have been borne out in the IBD com­munity where historically patients underwent prolonged usage of TPN for malab­sorption and short gut. While studies have shown both TPN and EN are effective at decreasing the risk of surgical complications compared to standard dietary interven­tion, EN has been shown to be superior to TPN with a number needed to treat of 2 to prevent surgical complications [30]. One downside of EN, however, is that the enteral feeds tend to be foul tasting and difcult to ingest, requiring prolonged placement of a nasogastric tube for up to 4weeks prior to surgery. TPN tends to be easier to admin­ister, and thus, when given the options, patients will often prefer TPN.
Preoperative immunonutrition is also a useful adjunct in colon and rectal surgery. It is well documented that surgery leads to a state of relative immune suppression in the perioperative period. Immunonutrition usually consists of supplements taken for a week prior to surgery consisting of some combination of arginine, glutamine, branched-chain amino acids, omega-3 fatty acids, and nucleotides. These are designed to target mucosal barrier function, cellular defense, and local and systemic inammation [31]. A large meta-analysis of immunonutrition showed that while it does not improve mortality, it does decrease the risk of overall complication and infectious complications and shortened hospital stay. The caveat to these data is that when substratied to industry-sponsored vs nonsponsored trials, only the industry sponsored trials demonstrated these benets [32].
Obesity
Obesity has been shown to increase the risk of almost every type of surgical compli­cation in the colon and rectal surgery patient [33]. Having a plan in place for miti­gating the risks of obesity is critical in ensuring optimal patient outcomes. The extremely obese should not be considered for elective surgery without undergoing some manner of weight loss program. This may ultimately include the consideration of bariatric surgery prior to elective colorectal procedures in an attempt to optimize the patient. There are also newer endoluminal approaches to weight loss which carry a lower risk of complications while still achieving modest improvements in both weight loss and correcting the various comorbidities associated with obesity [34]. Morbidly obese patients who can delay their colorectal procedure should be referred to a surgical weight loss team to undergo evaluation.
Many patients will not be able to undergo this long course of evaluation and treatment prior to their surgical intervention. A very low calorie liquid diet has been shown to decrease fat and in particular visceral fat in the preoperative period [35,
9 Checklist forPatients andOR Team inPreparation forLaparoscopic Colorectal…
121
36]. By decreasing visceral fat, specically a surgeon can gain length and reach of
bowel. This diet can be particularly helpful in procedures such as low anterior resec­tions and ileal pouch-anal anastomosis where bowel length is crucial. Very low calo­rie liquid diets usually have the patient consume nutritional shakes that make up less than 800kcal/day for 1–4weeks. The amount of fat loss correlates to the time the patient consumes this diet, and it should be done under the direction of a medical or surgical weight loss specialist to ensure that the patients are consuming the appro­priate macronutrients.
For those patients who must undergo surgery prior to weight loss, it is important to understand the risks obesity imparts upon the colon and rectal surgery patient. Hernia rates and wound complications are signicantly increased in these patients. A minimally invasive approach and off-midline extraction may be helpful in mini­mizing these wound complications [33, 37]. Surgical site infections are also increased in this population [33]. This may mean that an otherwise uneventful case may still benet from anastomotic diversion in an attempt to minimize the risk of a leak. These patients may also benet from drains in their subcutaneous tissues to minimize the risk of infected fat necrosis. Obese patients are also at an increased risk of respiratory and cardiovascular complications from anesthesia [33]. Therefore, it is helpful to include the anesthesia team in your surgical planning and consider prolonged postoperative monitoring for adverse events.
Renal Impairment
Chronic dialysis has been demonstrated to increase the risk of major complications from elective colorectal procedures by at least 2.5-fold and mortality by seven-fold [38]. These patients are particularly difcult to manage postoperatively especially with regard to managing their uid balance. If these patients present with sepsis, it can be quite difcult to ensure that they maintain the appropriate intravascular vol­ume to support their circulatory system without putting the patient into pulmonary edema. These patients are at a signicantly increased risk of both bleeding and VTE [38]. And because of this, it is crucial to carefully manage any postoperative antico­agulation. Patients on dialysis should be managed in conjunction with a nephrolo­gist who should see the patient prior to surgery to ensure that they are optimized. Dialysis should be optimally timed for surgery. It has been shown that an interval of less than 7hours between dialysis and surgery can lead to postoperative hypoten­sion due to the depleted intravascular state with which these patients undergo sur­gery [39]. Therefore, it is likely best to dialyze a patient the day prior to surgery to ensure they are undergoing their procedure at euvolemia.
Chronic kidney disease (CKD) not on dialysis also imparts an increased risk of perioperative complications. CKD patients undergoing colorectal resections were more likely to develop cardiovascular complications postoperatively and have a greater than two-fold risk of 30-day mortality [40]. These patients have the potential to be more dysregulated than the dialysis patients depending on their degree of renal impairment. Uremia can lead to a pro-inammatory state which can lead to an increased risk of atherosclerotic complications as well as infections and bleeding problems. These patients are also often malnourished and volume overloaded, their
122
S. Eisenstein and A. L. Grucela
electrolytes are unbalanced, and they have relative immune suppression. These patients are also often anemic and may benet from preoperative erythropoietin. When possible their renal function should be optimized as much as possible, and electrolytes should be checked immediately prior to surgery and frequently through­out their procedures.
Preoperative Stoma Marking
Preoperative stoma marking should be arranged for all patients undergoing colon and rectal surgery who may require a stoma at the time of their procedure. A frank conversation about the risks of colostomy or ileostomy is absolutely necessary before attempting bowel surgery. Patients should be aware of the likelihood of this outcome prior to undergoing surgery.
The surgeon may elect to perform their own marking, taking into consideration where the patient’s belt line may fall and then evaluating the abdominal contours. The patient should be evaluated in a variety of positions including sitting and supine. Creases, folds, and surgical scars should be avoided as they are a common site of leakage. Stoma marking should occur medial to the lateral border of the rectus abdominis muscle which can be easily palpated by having the patient sit up part way from the supine position, putting this muscle on tension. Oftentimes, it is necessary to mark multiple locations, either bilaterally or in the upper and lower abdomen depending on the patient’s habitus and the potential for different types of stomas which could be created at the time of surgery.
It is often much more benecial for the patient to be marked by an enterostomal therapist (EST) or a wound, ostomy, and continence nurse (WOCN). These special­ists not only mark the patient prior to surgery, but they help educate the patient on what life with a stoma may be like. They introduce the patients to the equipment and help them gain a familiarity. Oftentimes these nurses will see the patients in the hospital and continue their education prior to and post discharge. For more details on stomas, please refer to Chap. 36 on optimizing stoma function and quality of life.
Preoperative Patient Education
Patient education is a critical part of the enhanced recovery process and of manag­ing expectations of what they will experience during their postop period/hospital stay and at home. Patient education materials should be distributed including the preoperative plan and preparation and what to expect. See Fig.9.1 for an example. These materials have been demonstrated to help assuage patient’s fears of the unknown and have been demonstrated to decrease length of hospital stay [41].
Current enhanced recovery and surgical site infection (SSI) prevention protocol bundles may include aspects to improve return of bowel function, improved length of stay, and decrease wound infection rates. These are often institution-specic but
9 Checklist forPatients andOR Team inPreparation forLaparoscopic Colorectal…
123
Fig. 9.1 NYU Langone Medical Center colon pathway. (Used with permission. Copyright ©
NYU Langone Health)
124
S. Eisenstein and A. L. Grucela
Fig. 9.1 (continued)
9 Checklist forPatients andOR Team inPreparation forLaparoscopic Colorectal…
125
Fig. 9.1 (continued)
126
S. Eisenstein and A. L. Grucela
Fig. 9.1 (continued)
may include mechanical and antibiotic bowel preparation, carbohydrate loading/ drinks, chlorhexidine shower, or wipes. For more specic recommendations, please refer to the chapters on enhanced recovery protocols (Chap. 7) in colorectal surgery and on bowel preparation (Chap. 8) in colorectal surgery.
9 Checklist forPatients andOR Team inPreparation forLaparoscopic Colorectal…
127
Operative Setup, Pitfalls, andTroubleshooting
Local, Regional, andEpidural Anesthesia
Multimodal analgesia is an important part of postoperative recovery after laparo­scopic colon and rectal surgery as minimizing the use of narcotics aids in intestinal recovery. Patients should be evaluated prior to surgery for any effective adjunct to their postoperative pain control which may help minimize the postoperative use of narcotics and thus facilitate a quicker return of bowel function.
Transversus abdominis plane (TAP) blocks are a mainstay of perioperative abdominal anesthesia. Local anesthetic is injected into the neurovascular plane between the transversus abdominis and the internal oblique. This effectively blocks T7-L1 innervation to the abdominal wall for up to the rst 24hours after surgery, depending on the type of local anesthetic used. This can be done during laparo­scopic surgery under direct visualization, or it can be done preoperatively using ultrasound guidance by the surgeon or anesthesiologist. Studies comparing TAP block to local wound inltration have demonstrated similar visual analog scale (VAS) pain scores during the rst 24hours, but they have also demonstrated a sig­nicant decrease in narcotic use during that same time period [42, 43], demonstrat­ing that this can be a useful adjunct in aiding return of bowel function to expedite postoperative recovery.
There is extensive evidence that thoracic epidural anesthesia (TEA) decreases postoperative pain and narcotic use, expediting the recovery of bowel function in open surgery. The evidence for TEA usage in laparoscopic surgery is less conclu­sive. Several studies have examined the impact of epidural anesthesia on postopera­tive outcomes from laparoscopic colectomy and proctectomy. Most have shown that TEA leads to longer hospital stay, increased costs, and no decrease in postoperative ileus [4446]. Pain score improvement versus conventional postoperative narcotic analgesia varies but generally is not better [4446]. These studies do have several problems, however, as there is some heterogeneity as to which patients receive epi­dural narcotics as opposed to just local anesthetic as well as including a diverse group of surgeries. Many of the studies are also retrospective, and therefore the TEA patients tend to be the ones with more risk factors for postoperative complica­tions. Patients being considered for laparoscopic procedures who have a high risk of conversion based on preoperative factors to open should be considered for TEA as this can be removed in the early postoperative period if the surgery stays minimally invasive.
Intravenous lidocaine infusions have been used as an adjunct both during anes­thesia and postoperatively in the recovery and on the oor. Preliminary results of multiple studies have shown less postoperative pain, less narcotic use with earlier return of bowel function, and no adverse events [47, 48]. Patients need to be moni­tored, which can result in resistance in adaptation; however, cardiac complications such as arrhythmias and other adverse effects are rare. With a sound, data-driven protocol and team education, this can be easily employed.